[26-000910] the lab requires hematology panel - sequencing somatic mutations in bone marrow samples in order to take results from this test to provide guidance in treatment /diagnosis of disease.…
Active Purchase Order Awarded Last action
- Contract number
- 75N92026P00028
- Awardee
-
Genomic Testing Cooperative, LCA UEI NMAYSL9NW6M9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,000
Award facts
- Contract value 100% obligated
- $24,000.00 Current and potential, with all options
- Completion date 87% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Lake Forest, CA 92630, USA
Award details come from SAM.gov/FPDS.
About this award
The National Heart, Lung and Blood Institute awarded a $24,000 purchase order contract to Genomic Testing Cooperative, LCA, a small disadvantaged business located in Lake Forest, California, for hematology panel sequencing and somatic mutation analysis services. The contract, which commenced on December 22, 2025 and extends through December 21, 2026, requires the contractor to conduct next-generation sequencing of bone marrow samples to identify somatic mutations that will provide guidance for disease diagnosis and treatment protocols. This firm fixed-price contract was awarded without a set-aside designation and represents the type of specialized genomic diagnostic work that NHLBI regularly procures to support its research and clinical initiatives in hematological disease understanding.
Genomic Testing Cooperative, LCA has established a track record of delivering high-precision genomic testing services exclusively to NHLBI through multiple purchase order contracts, with individual awards ranging from $15,000 to $114,000. The company's core competency involves comprehensive gene panel sequencing—typically 177-gene panels—designed to detect mutations critical for understanding blood disorders and informing clinical decision-making. As a small disadvantaged business contractor based in California, the firm supports NHLBI's mission to advance understanding of diseases of the heart, lung, blood, and sleep through specialized molecular diagnostic capabilities that enable precision medicine approaches in federal research settings.
Description
[26-000910] the lab requires hematology panel - sequencing somatic mutations in bone marrow samples in order to take results from this test to provide guidance in treatment /diagnosis of disease. POP 12/22/2025 - 12/21/2026.
Quick answers
Who was awarded contract 75N92026P00028?
75N92026P00028 was awarded to Genomic Testing Cooperative, LCA by National Heart Lung and Blood Institute (National Institutes of Health) on December 22, 2025.
How much is contract 75N92026P00028 worth?
The government has obligated $24,000 on 75N92026P00028.
Was contract 75N92026P00028 competed?
The extent of competition for 75N92026P00028 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award